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Background
ATL is a highly aggressive leukemia/lymphoma which
was first proposed as a new disease entity in 1977. The
long clinical latency and low incidence of ATL indicate
that some genetic changes are involved in malignant
transformation and monoclonal expansion of HTLV-1-
infected cells. Monoclonal proliferation of HTLV-1-
infected cells is observed in a part of the virus carriers,
who are considered to be the high risk group for devel-
opment of ATL [1].
We reviewed the process of senescence and how pro-
teins allow the monoclonal proliferation of ATL cells.
Results
Constitutive activation of STAT as well as functional
impairment and stabilization of p53 protein found in
t h eP B M C so fA T Lp a t i e n t sa r es u p p o s e dt ob eo n e
base for ATL development [2,3]. In addition to deletion
and/or methylation of the p16INK4A gene, they suggest
the inhibition of senescence in ATL cells.
Furthermore, the soluble form of CD30 (sCD30) is
elevated in serum of ATL patients and correlates with
the aggressiveness of ATL [4] (Our observation) and it
is useful marker which indicates the intervention of
initiation therapy (Our observation) suggesting that
sCD30 allows the proliferation and survival of ATL cells.
Conclusions
Not only the inhibition of senescence by impaired func-
tion or constitutive activation of proteins in ATL cells,
but also immune regulation by soluble proteins in
serum of HTLV-1-infected patients must be required
for the progression of ATL.
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